The albumin–cyanine dye complexes, in which albumin serves as an active targeting carrier for the delivery of imaging agents to tumor sites, could be stable in systemic circulation to minimize off-target payload release after systemic administration [19,20]. This evidence concerns the gene ALB and neoplasm.